GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Gross Profit

Nirvana Life Sciences (XCNQ:NIRV) Gross Profit : C$0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Gross Profit?

Nirvana Life Sciences's gross profit for the three months ended in Jan. 2024 was C$0.00 Mil. Nirvana Life Sciences's gross profit for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Nirvana Life Sciences's gross profit for the three months ended in Jan. 2024 was C$0.00 Mil. Nirvana Life Sciences's Revenue for the three months ended in Jan. 2024 was C$0.00 Mil. Therefore, Nirvana Life Sciences's Gross Margin % for the quarter that ended in Jan. 2024 was N/A%.

Nirvana Life Sciences had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage


Nirvana Life Sciences Gross Profit Historical Data

The historical data trend for Nirvana Life Sciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Gross Profit Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23
Gross Profit
Get a 7-Day Free Trial - - - - -

Nirvana Life Sciences Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nirvana Life Sciences's Gross Profit

For the Biotechnology subindustry, Nirvana Life Sciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nirvana Life Sciences's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's Gross Profit falls into.



Nirvana Life Sciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Nirvana Life Sciences's Gross Profit for the fiscal year that ended in Apr. 2023 is calculated as

Gross Profit (A: Apr. 2023 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Nirvana Life Sciences's Gross Profit for the quarter that ended in Jan. 2024 is calculated as

Gross Profit (Q: Jan. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Nirvana Life Sciences's Gross Margin % for the quarter that ended in Jan. 2024 is calculated as

Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Nirvana Life Sciences  (XCNQ:NIRV) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Nirvana Life Sciences had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage


Nirvana Life Sciences Gross Profit Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Nirvana Life Sciences (XCNQ:NIRV) Business Description

Traded in Other Exchanges
N/A
Address
650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines